• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌肝内浸润的模式与范围——一项基于肝脏全景数字病理学的病例对照研究

Pattern and extent of intrahepatic infiltration of perihilar cholangiocarcinoma - a case-control study based on liver panoramic digital pathology.

作者信息

Jin Shuo, Jiang Nan, Zhao Jing-Min, Xiao Ying, Wang Si-Yuan, Xiang Can-Hong, Lu Qian, Shan Si-Qiao, Ruan Hao-Tian, Yu Shao-Qing, Zeng Jian-Ping, Yang Shi-Zhong, Li Li, Dong Jia-Hong

机构信息

HepatopancreLatobiliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology, Ministry of Education, School of Clinical Medicine, Tsinghua University, Beijing, China.

Research Unit of Precision Hepatobiliary Surgery Paradigm, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Int J Surg. 2025 Jan 1;111(1):31-39. doi: 10.1097/JS9.0000000000002040.

DOI:10.1097/JS9.0000000000002040
PMID:39166939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11745584/
Abstract

BACKGROUND

The extent of intrahepatic infiltration of perihilar cholangiocarcinoma (PHCC) remains unclear. This research aimed to explore the pattern and extent of intrahepatic infiltration of PHCC to guide surgical treatment and pathological research.

MATERIALS AND METHODS

This study included 62 patients diagnosed with PHCC who underwent major hepatectomy. A whole-mount digital liver pathology system (WDLPS) for hepatectomy specimens greater than 10×10 cm was used to panoramically assess the intrahepatic infiltration extent of PHCC.

RESULTS

The distal intrahepatic infiltration (DIHI) and radial liver invasion (RLI) were important parts of intrahepatic infiltration for PHCC explored by WDLPS. The study confirmed that 75.8% of PHCCs had RLI and the infiltration distance in all patients were within 15 000 µm, 62.9% of PHCCs had DIHI greater than 1 cm away from the main tumor in the liver parenchyma. The recurrence-free survival rates and overall survival rates of patients with DIHI were poorer than the patients without DIHI ( P <0.0001, P =0.0038). Arterial invasion on the resected side could be an excellent predictor. A total of 105 liver lobes were resected from 62 PHCC patients. The invasion rates of the left lateral, left medial, right anterior, and right posterior lobe of PHCC were 79%, 100%, 100%, and 69%, respectively.

CONCLUSION

The presence of DIHI in most PHCCs was a significant factor for the poor survival. Based on the extent of intrahepatic infiltration, minor hepatectomy was not suitable as the curative surgery for PHCC. Major hepatectomy and liver transplantation were the ideal radical treatment.

摘要

背景

肝门部胆管癌(PHCC)肝内浸润范围尚不清楚。本研究旨在探讨PHCC肝内浸润的模式和范围,以指导手术治疗和病理研究。

材料与方法

本研究纳入62例接受大肝切除术的PHCC患者。使用全层数字肝脏病理系统(WDLPS)对大于10×10 cm的肝切除标本进行全景评估,以确定PHCC的肝内浸润范围。

结果

肝内远端浸润(DIHI)和肝脏径向侵犯(RLI)是WDLPS所探索的PHCC肝内浸润的重要部分。研究证实,75.8%的PHCC存在RLI,所有患者的浸润距离均在15000 µm以内,62.9%的PHCC在肝实质内的DIHI距离主肿瘤大于1 cm。DIHI患者的无复发生存率和总生存率低于无DIHI的患者(P<0.0001,P=0.0038)。切除侧的动脉侵犯可能是一个很好的预测指标。62例PHCC患者共切除105个肝叶。PHCC对肝左外叶、左内叶、右前叶和右后叶的侵犯率分别为79%、100%、100%和69%。

结论

大多数PHCC中DIHI的存在是生存不良的重要因素。基于肝内浸润范围,小范围肝切除术不适用于PHCC的根治性手术。大范围肝切除术和肝移植是理想的根治性治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/74c0a4f9ec92/js9-111-0031-s002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/7ebbc3336c50/js9-111-0031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/9ec971386679/js9-111-0031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/4b0425343a37/js9-111-0031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/4b38f25b9912/js9-111-0031-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/48f2aed10c13/js9-111-0031-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/74c0a4f9ec92/js9-111-0031-s002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/7ebbc3336c50/js9-111-0031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/9ec971386679/js9-111-0031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/4b0425343a37/js9-111-0031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/4b38f25b9912/js9-111-0031-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/48f2aed10c13/js9-111-0031-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4a/11745584/74c0a4f9ec92/js9-111-0031-s002.jpg

相似文献

1
Pattern and extent of intrahepatic infiltration of perihilar cholangiocarcinoma - a case-control study based on liver panoramic digital pathology.肝门部胆管癌肝内浸润的模式与范围——一项基于肝脏全景数字病理学的病例对照研究
Int J Surg. 2025 Jan 1;111(1):31-39. doi: 10.1097/JS9.0000000000002040.
2
The survival benefit of surgery for perihilar cholangiocarcinoma in octogenarians: Shinshu University experience.高龄患者肝门部胆管癌行手术治疗的生存获益:日本信州大学经验。
J Surg Oncol. 2021 Jul;124(1):67-78. doi: 10.1002/jso.26488. Epub 2021 Apr 12.
3
Different biliary tract cancers, same operation: Importance of cancer origin in patients with hilar-invading tumors.不同的胆道癌,相同的手术:肿瘤起源对侵犯肝门部肿瘤患者的重要性。
Scand J Surg. 2025 Mar;114(1):35-43. doi: 10.1177/14574969241282480. Epub 2024 Oct 8.
4
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
5
Occult synchronous liver metastasis from perihilar cholangiocarcinoma.肝门部胆管癌隐匿性同步肝转移。
Surgery. 2019 Sep;166(3):290-296. doi: 10.1016/j.surg.2019.04.029. Epub 2019 Jun 21.
6
High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.手术切除淋巴结阴性肝门周围胆管癌患者胆管边缘高级别发育不良/原位癌与生存不良相关:一项回顾性研究。
J Hepatobiliary Pancreat Sci. 2017 Aug;24(8):456-465. doi: 10.1002/jhbp.481. Epub 2017 Jul 3.
7
Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer.经实质肝门入路:一种治疗晚期肝门部胆管癌的新型手术技术。
Langenbecks Arch Surg. 2018 May;403(3):387-394. doi: 10.1007/s00423-017-1633-2. Epub 2017 Oct 23.
8
A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma.肝门周围胆管癌切缘状态的研究。
Ann Surg. 2021 Mar 1;273(3):572-578. doi: 10.1097/SLA.0000000000003305.
9
Robotic Klatskin Type 3A Resection with Biliary Reconstruction: Description of Surgical Technique and Outcomes of Initial Series.机器人 Klatskin 型 3A 切除术联合胆道重建:手术技术描述及初步系列结果。
Ann Surg Oncol. 2023 Dec;30(13):8559-8560. doi: 10.1245/s10434-023-14256-y. Epub 2023 Sep 8.
10
Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.肝门部胆管癌根治性切除术后累及肝门的肝内胆管细胞癌的围手术期和长期预后:与周围型肝内胆管细胞癌和肝门部胆管癌的比较。
Surgery. 2018 May;163(5):1114-1120. doi: 10.1016/j.surg.2018.01.001. Epub 2018 Feb 2.

本文引用的文献

1
Minor hepatectomy combined with cholangioplasty and cholangiojejunostomy for Bismuth II hilar cholangiocarcinoma: A propensity score matching analysis.肝门部胆管癌Ⅱ型行肝部分切除联合胆管整形和胆肠吻合术的疗效分析:倾向评分匹配研究
Eur J Surg Oncol. 2024 Jun;50(6):108339. doi: 10.1016/j.ejso.2024.108339. Epub 2024 Apr 12.
2
Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?肝门部胆管癌的实质保留肝切除术:重症患者的契机?
Visc Med. 2024 Apr;40(2):53-60. doi: 10.1159/000537884. Epub 2024 Mar 22.
3
STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery.
STROCSS 2021:加强外科学队列研究、横断面研究和病例对照研究报告规范。
Int J Surg. 2021 Dec;96:106165. doi: 10.1016/j.ijsu.2021.106165. Epub 2021 Nov 11.
4
Extended Right-hemihepatectomy Is Preferred for Perihilar Cholangiocarcinoma.肝门部胆管癌首选扩大右半肝切除术。
Ann Surg. 2021 Jul 1;274(1):33-34. doi: 10.1097/SLA.0000000000004821.
5
Biliary tract cancer.胆道癌。
Lancet. 2021 Jan 30;397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7.
6
Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma.术前门静脉栓塞的结构性应用对肝门周围胆管癌肝切除术后结局的影响。
BJS Open. 2020 Jun;4(3):449-455. doi: 10.1002/bjs5.50273. Epub 2020 Mar 17.
7
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.
8
Hilar en bloc resection for hilar cholangiocarcinoma in patients with limited liver capacities-preserving parts of liver segment 4.对肝容量有限的肝门部胆管癌患者行肝门整块切除并保留肝段4的部分组织。
Eur Surg. 2018;50(1):22-29. doi: 10.1007/s10353-017-0507-8. Epub 2018 Jan 2.
9
Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.根治性切除后肝门周围胆管癌的复发:采用密切术后随访方法的大型队列分析。
Surgery. 2018 Apr;163(4):732-738. doi: 10.1016/j.surg.2017.08.011. Epub 2018 Jan 11.
10
The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.尾状叶切除术对肝门部胆管癌患者切缘状态和预后的影响:来自美国肝外胆管恶性肿瘤联盟的多机构分析。
Surgery. 2018 Apr;163(4):726-731. doi: 10.1016/j.surg.2017.10.028. Epub 2018 Jan 3.